Myocardial infarction and short- or long-term risk of a subsequent cancer diagnosis: a Danish Nationwide Cohort Study
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2024.12.008 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Jens Sundbøll und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark; Department of Cardiology, Regional Hospital Gøds…. Hauptthemen laut MEDLINE: Myocardial Infarction, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Aarhus University.
Abstract (Originalsprache)
BACKGROUND: Growing evidence suggests that myocardial infarction (MI) may be a marker of cancer risk, but many aspects of this relation are poorly understood. OBJECTIVES: To examine the short- and long-term risk of incident cancer in patients presenting with MI. METHODS: Using nationwide population-based Danish health registries, we identified all patients with a first-time diagnosis of MI (1995-2021) and followed them for up to 28 years for any subsequent diagnosis of cancer. We computed risks and standardized incidence ratios with 95% CIs as the observed number of cancers relative to the expected number based on national cancer incidence rates by sex, age, and calendar year. RESULTS: Among 185 065 patients diagnosed with MI, we observed 25 315 subsequent cancers. The risk of any cancer was 2.4% after 1 year of follow-up, increasing to 25.8% after 28 years, taking the competing risks of death into account. During the first year of follow-up, the standardized incidence ratio of any cancer was 1.67 (95% CI, 1.62-1.73). The standardized incidence ratio remained moderately elevated during 2 to 5 years (1.03; 95% CI, 1.01-1.05) and beyond 5 years (1.07; 95% CI, 1.05-1.09). The strongest associations were found for hematological as well as obesity- and smoking-related cancers during the first year of follow-up, whereas primarily, the risk of smoking-related cancers remained elevated throughout the entire follow-up period. CONCLUSION: MI was associated with subsequent risk of cancer, driven by hematologic, obesity-, and smoking-related cancers in the short term and smoking-related cancers in the long term.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark; Department of Cardiology, Regional Hospital Gødstrup, Herning, Denmark. Electronic address: jensms@rm.dk.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.
- Department of Cardiology, Regional Hospital Gødstrup, Herning, Denmark.
- Department of Clinical Medicine, Cardiology and Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark; Center for Population Medicine, Aarhus University Hospital, and Aarhus University, Aarhus, Denmark.
Förderung
- Aarhus University
Zitieren
APA
Sundbøll, J., Veres, K., Troelsen, F. S., Würtz, M., Bøtker, H. E., & Sørensen, H. T. (2025). Myocardial infarction and short- or long-term risk of a subsequent cancer diagnosis: a Danish Nationwide Cohort Study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.12.008
Vancouver
Sundbøll J, Veres K, Troelsen FS, Würtz M, Bøtker HE, Sørensen HT. Myocardial infarction and short- or long-term risk of a subsequent cancer diagnosis: a Danish Nationwide Cohort Study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.12.008
BibTeX
@article{Sundbll2025,
author = {Sundbøll, Jens and Veres, Katalin and Troelsen, Frederikke S and Würtz, Morten and Bøtker, Hans Erik and Sørensen, Henrik Toft},
title = {Myocardial infarction and short- or long-term risk of a subsequent cancer diagnosis: a Danish Nationwide Cohort Study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2024.12.008}
}
EUVIMED